02817nam 2200601 a 450 991096939560332120251116221100.01-61668-400-3(CKB)2560000000068608(EBL)3020651(SSID)ssj0000411009(PQKBManifestationID)12155024(PQKBTitleCode)TC0000411009(PQKBWorkID)10354774(PQKB)10983082(MiAaPQ)EBC3020651(Au-PeEL)EBL3020651(CaPaEBR)ebr10678061(OCoLC)688293886(BIP)43288389(BIP)28841183(EXLCZ)99256000000006860820100111d2010 uy 0engur|n|---|||||txtccrAdvanced cancer pain and quality of life /Edward Chow and Joav Merrick, editors1st ed.New York Nova Science Publishersc20101 online resource (346 p.)Health and human developmentDescription based upon print version of record.1-61668-207-8 Includes bibliographical references and index.section 1. Pain management -- section 2. Palliative radiotherapy -- section 3. Advanced cancer -- section 4. Quality of life -- section 5. Some case reports -- section 6. Acknowledgments.An estimated 166,400 new cases of cancer will occur in Canada in 2008. Bone metastases unfortunately remain a common site of recurrence, with breast and prostate cancer patients representing a substantial proportion of this population. Metastatic bone disease is associated with significant morbidity and mortality. Pain is experienced by up to two thirds of patients. The prognosis for patients with bone metastases is highly influenced by tumor type, performance status, and the presence of extraosseous disease. The median survival has been significantly longer in breast cancer patients with a first relapse in the axial skeleton (24 months) versus patients with initial relapse in the liver (3 months) (2). Survival after diagnosis of bone metastases is influenced by the subsequent development of extraosseous metastatic sites: 1.6 years versus 2.1 years in patients with bone-only disease.Health and human development series.CancerPalliative treatmentCancer painCancerPalliative treatment.Cancer pain.616.99/406Chow Edward1622829Merrick Joav1950-884058MiAaPQMiAaPQMiAaPQBOOK9910969395603321Advanced cancer4469647UNINA